Want to see IN:SPARC full AI Analyst Report?
Sun Pharma Advanced Research Co. Ltd. (SPARC) Income Statement
Sun Pharma Advanced Research Co. Ltd. Income Statement
Last quarter (Q1 2027), Sun Pharma Advanced Research Co. Ltd.'s total revenue was $399.20M, an increase of 314.11% from the same quarter last year. In Q1, Sun Pharma Advanced Research Co. Ltd.'s net income was $-207.80M. See Sun Pharma Advanced Research Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 18.79B | $ 717.70M | $ 755.45M | $ 2.39B | $ 1.37B | |
| $ 17.27B | $ 486.50M | $ -1.24B | $ 821.21M | $ 105.52M | |
| $ 1.39B | $ 3.27B | $ 7.74B | $ 3.06B | $ 4.90B | |
| Depreciation and Amortization | $ 102.10M | $ 123.90M | $ 125.11M | $ 117.71M | $ 101.62M |
| $ 15.99B | $ -3.23B | $ -3.73B | $ -2.03B | $ -1.80B | |
| $ 15.89B | $ -2.78B | $ -4.12B | $ -2.24B | $ -1.97B | |
| $ -355.40M | $ -648.00M | $ 246.72M | $ 10.61M | $ -73.23M | |
| $ 15.53B | $ -3.43B | $ -3.87B | $ -2.23B | $ -2.03B | |
| $ 15.53B | $ -3.43B | $ -3.87B | $ -2.23B | $ -2.03B | |
| Per Share Metrics | |||||
| Basic EPS | $ 47.86 | $ -10.55 | $ -11.93 | $ -7.82 | $ -7.73 |
| Diluted EPS | $ 47.86 | $ -10.55 | $ -11.93 | $ -7.82 | $ -7.73 |
| Weighted Average Shares Outstanding | 324.53M | 324.65M | 324.52M | 284.70M | 263.14M |
| Weighted Average Shares Outstanding (Diluted) | 324.53M | 324.65M | 324.52M | 284.70M | 263.14M |
Currency in INR
